Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;23(4):441-447.
doi: 10.1111/hiv.13259. Epub 2022 Feb 18.

Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study

Nelly Courvoisier  1 , Chiara Storari  1 , Saphir Lesage  1 , Lucie Vittoz  1 , Charlotte Barbieux  2 , Isabelle Peytremann-Bridevaux  1 , Ingrid Gilles  1 , Alexandra Calmy  2
Affiliations

Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study

Nelly Courvoisier et al. HIV Med. 2022 Apr.

Abstract

Objectives: Women are underrepresented in most HIV clinical trials in Western countries, but their participation remains crucial as the lack of information on sex- and gender-specific effects may hinder the safety and efficacy of antiretroviral treatments. The aim of this study was to identify barriers to and facilitators of women's participation in HIV clinical trials in Switzerland.

Methods: We conducted semi-structured interviews among 20 women with HIV to explore factors associated with non-participation in clinical trials. The interviewer presented to participants a clinical trial's description and discussed it with them. Lexicometric analysis on transcribed interviews identified three themes and eight sub-themes related to the pros and cons of participation in HIV clinical trials.

Results: Participants evoked mainly decision-making drivers, concerns for women living with HIV and treatment side-effects. They highlighted the need for extensive information provided by trusted healthcare professionals on the research process as central to the decision to enrol in HIV clinical trials. Familial responsibilities were clearly identified as barriers to their participation, but not pregnancy. Additional preoccupations were other health concerns and comorbidities and the consequences of stopping ongoing antiretroviral treatments.

Conclusions: To overcome the barriers to the participation of women living with HIV in clinical research in Western countries, healthcare professionals and researchers should increase women's research literacy by involving them in the study design and by tailoring clinical trials to their social roles and health concerns. Trust in professionals is a facilitator of enrolment of women living with HIV that should be maintained.

Keywords: HIV clinical trial; HIV women; gender perspective; people living with HIV; qualitative research.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Themes, sub‐themes, typical words and excerpts from the lexicometric analysis. Percentages correspond to the proportion of text included in the analysis
See this image and copyright information in PMC

References

    1. Curno MJ, Rossi S, Hodges‐Mameletzis I, Johnston R, Price MA, Heidari S. A systematic review of the inclusion (or exclusion) of women in HIV research: from clinical studies of antiretrovirals and vaccines to cure strategies. J Acquir Immune Defic Syndr (1999). 2016;71(2):181‐188. - PubMed
    1. Dubé K, Hosey L, Starr K, et al. Participant perspectives in an HIV cure‐related trial conducted exclusively in women in the United States: results from AIDS clinical trials group 5366. AIDS Res Hum Retroviruses. 2020;36(4):268‐282. - PMC - PubMed
    1. Merkatz RB, Temple R, Subel S, Feiden K, Kessler DA. Women in clinical trials of new drugs. A change in food and drug administration policy. The working group on women in clinical trials. N Engl J Med. 1993;329(4):292‐296. - PubMed
    1. Gianella S, Tsibris A, Barr L, Godfrey C. Barriers to a cure for HIV in women. J Int AIDS Soc. 2016;19(1):20706. - PMC - PubMed
    1. Berlin JA, Ellenberg SS. Inclusion of women in clinical trials. BMC Med. 2009;7(1):56. - PMC - PubMed

Substances